The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations
Authors
Keywords
-
Journal
CLINICAL PHARMACOKINETICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-12
DOI
10.1007/s40262-020-00931-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects
- (2020) Julie Crockett et al. EPILEPSIA
- The effect of piperine on oral absorption of cannabidiol following acute vs. chronic administration
- (2020) Dvora Izgelov et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Intestinal Lymph Flow, and Lipid and Drug Transport Scale Allometrically From Pre-clinical Species to Humans
- (2020) Natalie L. Trevaskis et al. Frontiers in Physiology
- Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications
- (2020) Emilio Perucca et al. CNS DRUGS
- A perspective on the physicochemical and biopharmaceutic properties of marketed antiseizure drugs—From phenobarbital to cenobamate and beyond
- (2020) Reem Odi et al. EPILEPSIA
- Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers
- (2020) Dvora Izgelov et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment
- (2019) Lesley Taylor et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
- (2019) Valentina Franco et al. DRUGS
- Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy
- (2019) Angela K. Birnbaum et al. EPILEPSIA
- The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
- (2019) Mirko Koziolek et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Oral absorption and lymphatic transport of baicalein following drug–phospholipid complex incorporation in self-microemulsifying drug delivery systems
- (2019) Hengfeng Liao et al. International Journal of Nanomedicine
- A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects
- (2019) Katharina Knaub et al. MOLECULES
- A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment
- (2019) Bola Tayo et al. CLINICAL PHARMACOKINETICS
- Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system
- (2018) Jong Bong Lee et al. JOURNAL OF CONTROLLED RELEASE
- PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers
- (2018) Jacob Atsmon et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Critical In Vitro Characterization Methods of Lipid-Based Formulations for Oral Delivery: a Comprehensive Review
- (2018) Nitin Kumar Swarnakar et al. AAPS PHARMSCITECH
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development
- (2018) Meir Bialer et al. EPILEPSIA
- Lymphatic Drug Absorption via the Enterocytes: Pharmacokinetic Simulation, Modeling, and Considerations for Optimal Drug Development
- (2018) Dion R. Brocks et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration
- (2017) Irina Cherniakov et al. JOURNAL OF CONTROLLED RELEASE
- Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation
- (2017) Atheer Zgair et al. Scientific Reports
- Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral Bioavailability
- (2016) Luojuan Hu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Interaction of Drug or Food with Drug Transporters in Intestine and Liver
- (2015) Takeo Nakanishi et al. CURRENT DRUG METABOLISM
- Factors affecting intrasubject variability of PK exposure: absolute oral bioavailability and acidic nature of drugs
- (2015) Masahiko Sato et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans
- (2015) Alex F. Manini et al. Journal of Addiction Medicine
- From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity
- (2015) Natalie L. Trevaskis et al. NATURE REVIEWS DRUG DISCOVERY
- The role of molecular physicochemical properties and apolipoproteins in association of drugs with triglyceride-rich lipoproteins: in-silico prediction of uptake by chylomicrons
- (2009) Pavel Gershkovich et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Intestinal Lymphatic Transport Enhances the Post-Prandial Oral Bioavailability of a Novel Cannabinoid Receptor Agonist Via Avoidance of First-Pass Metabolism
- (2009) Natalie L. Trevaskis et al. PHARMACEUTICAL RESEARCH
- Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update
- (2007) Natalie L. Trevaskis et al. ADVANCED DRUG DELIVERY REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started